THIOXOTHIAZOLIDINE DERIVATIVE HAVING RAS FUNCTION INHIBITORY EFFECT
申请人:Kataoka Tohru
公开号:US20140194412A1
公开(公告)日:2014-07-10
The present invention provides an anticancer drug having a Ras function inhibitory action.
The present invention provides a Ras function inhibitor comprising a compound represented by the formula (I′):
wherein each symbol is as defined in the present specification, or a salt thereof.
Saccharin Aza Bioisosteres—Synthesis and Preclinical Property Comparisons
作者:Yantao Chen、Carl-Johan Aurell、Anna Pettersen、Richard J. Lewis、Martin A. Hayes、Matti Lepistö、Anna C. Jonson、Hanna Leek、Linda Thunberg
DOI:10.1021/acsmedchemlett.7b00137
日期:2017.6.8
Saccharin is a well-known scaffold in drug discovery. Herein, we report the synthesis and preclinical property comparisons of three bioisosteres of saccharin: aza-pseudosaccharins (cluster B), and two new types of aza-saccharins (clusters C and D). We demonstrate a convenient protocol to selectively synthesize products in cluster C or D when primary amines are used. Preclinical characterization of